REGENXBIO stockholders elect four Class I directors, approve 2025 equity plan

REGENXBIO Inc.

Four Class I directors elected: Fox (27.99M for), Glucksmann (29.26M), Simpson (32.80M), Zachary (29.18M) until 2028.
Ratified PricewaterhouseCoopers as independent auditor for FY2025: 41.17M for, 39,375 against.
Advisory approval of named executive officer compensation: 32.58M for, 1.76M against.
Advisory vote on frequency: 'Every 1 Year' received 33.15M votes; company will hold annual say-on-pay votes.
Approved 2025 Equity Incentive Plan: 27.40M for, 6.97M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.